Factor V Leiden ICD-10-CM Codes
Explore the ICD-10-CM codes pertinent to the Factor V Leiden genetic predisposition. A comprehensive coding guide for hereditary thrombophilia disorders.
What ICD-10 Codes are Used for Factor V Leiden
Factor V Leiden is a mutation of one of the clotting factors in the blood, leading to an increased risk of developing abnormal blood clots. The ICD-10-CM classification system provides specific codes for this genetic condition.
Here's the key ICD-10-CM code for Factor V Leiden:
D68.59: Other primary thrombophilia
Clinical Description: This code encompasses inherited thrombophilia conditions, including the Factor V Leiden mutation.
Which Factor V Leiden ICD Codes are Billable:
- D68.59: Yes
Clinical Information
- Factor V Leiden is the most prevalent inherited coagulation disorder in people of European ancestry.
- This mutation causes a change in clotting factor V, making it less susceptible to being inactivated, leading to hypercoagulability.
- Those with Factor V Leiden mutation have a heightened risk for venous thromboembolism, including deep vein thrombosis and pulmonary embolism.
- While many carriers of the mutation never develop abnormal clots, they are at an increased risk, especially when combined with other clotting risk factors.
- Treatment or preventive measures might involve anticoagulant medications, particularly if the individual has had previous clotting events.
Synonyms Include
- Activated protein C resistance
- Factor V mutation
- Genetic predisposition to clotting
- Hereditary thrombophilia
.png)
Commonly asked questions
The Factor V Leiden ICD-10-CM code should be utilized in medical records when diagnosing, treating, or documenting a patient known to have this particular genetic predisposition to increased clotting.
Factor V Leiden is usually diagnosed via a blood test, which may be prompted due to a personal or familial history of blood clots, or when other indicators of heightened clotting risk are evident.
A diagnosis code for Factor V Leiden offers a standardized manner to indicate that a patient possesses this specific genetic mutation increasing their risk of abnormal blood clots. This standardized coding aids in clinical care, research, and administrative functions like billing and insurance claims processing.
Related Guides
